Literature DB >> 16861486

Recurrent respiratory papillomatosis.

R A Tasca1, R W Clarke.   

Abstract

Recurrent respiratory papillomatosis (RRP) is a benign, often multi-focal neoplasm. A potentially fatal manifestation of human papilloma virus infection, the condition is characterised by multiple warty excrescences on the mucosal surface of the respiratory tract. RRP is rare--incidence is estimated at 3.5 per million person-years, with a prevalence of 4 in 100,000 children. Affected children usually require multiple interventions; the impact on patients, their families, and the healthcare system is considerable. Treatment of RRP accounts for an estimated dollar 109 million annual expenditure in the USA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861486      PMCID: PMC2083023          DOI: 10.1136/adc.2005.090514

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  31 in total

1.  Perinatal transmission of human papillomavirus from gravidas with latent infections.

Authors:  P Tenti; R Zappatore; P Migliora; A Spinillo; C Belloni; L Carnevali
Journal:  Obstet Gynecol       Date:  1999-04       Impact factor: 7.661

Review 2.  Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one?

Authors:  J R Kosko; C S Derkay
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1996-03       Impact factor: 1.675

3.  Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force.

Authors:  L R Armstrong; C S Derkay; W C Reeves
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-07

4.  Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.

Authors:  Georges de Bilderling; Eddy Bodart; Georges Lawson; David Tuerlinckx; Marc Remacle; Lieve Naesens; Erik De Clercq; Robert Snoeck
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

5.  Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.

Authors:  Annie S Lee; Clark A Rosen
Journal:  J Voice       Date:  2004-12       Impact factor: 2.009

6.  Extraesophageal acid reflux and recurrent respiratory papilloma in children.

Authors:  Margo McKenna; Linda Brodsky
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-05       Impact factor: 1.675

7.  Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).

Authors:  Hugo Nodarse-Cuní; Nora Iznaga-Marín; Ditza Viera-Alvarez; Hortensia Rodríguez-Gómez; Héctor Fernández-Fernández; Yazmín Blanco-López; Carmen Viada-González; Pedro López-Saura
Journal:  J Laryngol Otol       Date:  2004-09       Impact factor: 1.469

8.  Ribavirin treatment for juvenile respiratory papillomatosis.

Authors:  G A Morrison; B Kotecha; J N Evans
Journal:  J Laryngol Otol       Date:  1993-05       Impact factor: 1.469

9.  Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study.

Authors:  D R Endres; N M Bauman; D Burke; R J Smith
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-04       Impact factor: 1.547

10.  Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.

Authors:  David L Mandell; Ellis M Arjmand; David J Kay; Margaretha L Casselbrant; Clark A Rosen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-11
View more
  14 in total

1.  Modern imaging of the tracheo-bronchial tree.

Authors:  Archana T Laroia; Brad H Thompson; Sandeep T Laroia; Edwin van Beek
Journal:  World J Radiol       Date:  2010-07-28

2.  Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis.

Authors:  Ioannis N Mammas; George Sourvinos; Elena Vakonaki; Panagiota Giamarelou; Catherine Michael; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2010-03-07       Impact factor: 3.183

3.  Maternal condyloma acuminata infection in pregnancy and offspring long-term respiratory and infectious outcome.

Authors:  Ofir Sahar; Gil Gutvirtz; Tamar Wainstock; Eyal Sheiner
Journal:  Arch Gynecol Obstet       Date:  2022-06-01       Impact factor: 2.344

Review 4.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

Review 5.  Oncogenic activities of human papillomaviruses.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

Review 6.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

Review 7.  Recurrent respiratory papillomatosis: current and future perspectives.

Authors:  Marco Carifi; Domenico Napolitano; Morando Morandi; Danilo Dall'Olio
Journal:  Ther Clin Risk Manag       Date:  2015-05-05       Impact factor: 2.423

Review 8.  Current and future management of recurrent respiratory papillomatosis.

Authors:  Ryan Ivancic; Hassan Iqbal; Brad deSilva; Quintin Pan; Laura Matrka
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-01-14

Review 9.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

Review 10.  Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV.

Authors:  Ramya Kollipara; Erfon Ekhlassi; Christopher Downing; Jacqueline Guidry; Michael Lee; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.